logo

Diffusion Pharmaceuticals Inc. ( (DFFN)



Trade DFFN now with
  Date
  Headline
12/27/2017 8:03:24 AM Diffusion Commences Phase 3 Clinical Trial With Trans Sodium Crocetinate In Glioblastoma Multiforme
11/20/2017 8:04:49 AM Diffusion Regains Compliance With Nasdaq Capital Market Minimum Equity Rule
11/13/2017 8:12:58 AM Diffusion Pharma Q3 Net Income $5.09 Mln Vs. Net Loss $5.4 Mln Last Year
10/17/2017 7:34:58 AM Diffusion Pharma Gets Final FDA Protocol Guidance For Phase 3 Clinical Trial With TSC; Sees To Begin Trial By Year-End
7/31/2017 8:36:38 AM Diffusion Selects Contract Research Organization For Phase 3 Clinical Trial Of Lead Compound TSC
7/20/2017 8:34:19 AM Diffusion Pharma Achieves Drug Production Milestone For Phase 3 Clinical Trial In Inoperable GBM Brain Cancer
7/6/2017 8:05:49 AM Diffusion Pharmaceuticals Appoints Robert Ruffolo To Board Of Directors
4/4/2017 8:43:38 AM Diffusion Secures U.S. Patent For TSC As Therapeutic In Five Hypoxia-Related Indications